Triamcinolone acetonide 0.1% cream

DRUG2 trials

Sponsors

MC2 Therapeutics, University of California, San Diego

Conditions

Immunotherapy-related PruritusVasoconstriction

Phase 1

Evaluation of the Vasoconstriction Properties of MC2-01 Cream

CompletedNCT03758365

MC2 TherapeuticsVasoconstriction

Start: 2018-11-05End: 2018-11-23Updated: 2020-01-09

Phase 2

TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus

RecruitingNCT06748404

University of California, San DiegoImmunotherapy-related Pruritus

Start: 2025-01-31End: 2028-12-01Target: 28Updated: 2026-02-24